Caffeine

1. 2026-10-19issueIssued info_card
2. 2026-09-28runbrief run
3. 2026-09-27runbrief run
4. 2026-09-27runbrief run
5. 2026-09-27runbrief run
6. 2026-09-27runbrief run
7. 2026-09-27runbrief run
8. 2026-09-23runbrief run
9. 2026-09-18runbrief run
10. 2026-09-18runbrief run
11. 2026-09-18runbrief run
12. 2026-09-18revisionr1.a1
13. 2026-09-07srcThe effects of energy drink in combination with alcohol on performance and subjective awareness.
14. 2026-09-07srcCaffeine intake during pregnancy and adverse birth outcomes: a systematic review and dose-response meta-analysis.
15. 2026-09-07srcAcute intentional caffeine overdose treated preemptively with hemodialysis.
16. 2026-09-07srcEffects of caffeine on anxiety and panic attacks in patients with panic disorder: A systematic review and meta-analysis.
17. 2026-09-07srcSudden cardiac arrest occurring in temporal proximity to consumption of energy drinks.
18. 2026-09-07srcLow, but not high, dose caffeine is a readily available probe for adenosine actions.
19. 2026-09-07srcCaffeine-dependent changes of sleep-wake regulation: Evidence for adaptation after repeated intake.
20. 2026-09-07srcStructure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine.
21. 2026-09-07srcThe epidemiology of Parkinson's disease: risk factors and prevention.
22. 2026-09-07srcCharacterization of individuals seeking treatment for caffeine dependence.
23. 2026-09-07srcCaffeine may disrupt the impact of real-time drowsiness on cognitive performance: a double-blind, placebo-controlled small-sample study.
24. 2026-09-07srcTea, coffee, and caffeine intake and risk of dementia and Alzheimer's disease: a systematic review and meta-analysis of cohort studies.
25. 2026-09-07srcCaffeine therapy for apnea of prematurity.
26. 2026-09-07srcThe Effect of Caffeine Consumption and Acute Withdrawal on Resting-State fMRI Brain Connectivity, Mood and Cognition.
27. 2026-09-07srcCaffeine provokes adverse interactions with MDMA and related psychostimulants: mechanisms and mediators.
28. 2026-09-07srcArrhythmogenic effects of energy drinks.
29. 2026-09-07srcRegulatory status of caffeine in the United States.
30. 2026-09-07srcInternational Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.
31. 2026-09-07srcInternational society of sports nutrition position stand: caffeine and exercise performance.
32. 2026-09-07srcAssociation of Coffee Consumption and Prediagnostic Caffeine Metabolites With Incident Parkinson Disease in a Population-Based Cohort.
33. 2026-09-07srcExpression and characterization of purinergic receptors in rat middle meningeal artery--potential role in migraine.
34. 2026-09-07srcPresynaptic Control of Striatal Glutamatergic Neurotransmission by Adenosine A1-A2A Receptor Heteromers
35. 2026-09-07srcCaffeine: Cognitive and Physical Performance Enhancer or Psychoactive Drug?
36. 2026-09-07srcScientific Opinion on the safety of caffeine. EFSA 2015.
37. 2026-09-07srcCaffeine, mental health, and psychiatric disorders.
38. 2026-09-07srcCaffeine and adenosine.
39. 2026-09-07srcChronic caffeine consumption prevents memory disturbance in different animal models of memory decline.
40. 2026-09-07srcPharmacokinetics of Caffeine: A Systematic Analysis of Reported Data for Application in Metabolic Phenotyping and Liver Function Testing.
41. 2026-09-07srcPlasma Caffeine Levels and Risk of Alzheimer's Disease and Parkinson's Disease: Mendelian Randomization Study.
42. 2026-09-07srcCaffeine Withdrawal
43. 2026-09-07srcActions of caffeine in the brain with special reference to factors that contribute to its widespread use.
44. 2026-09-07srcDrug interactions with tobacco smoking. An update.
45. 2026-09-07srcLow daily 10-mg and 20-mg doses of fluvoxamine inhibit the metabolism of both caffeine (CYP1A2) and omeprazole (CYP2C19).
46. 2026-09-07srcOxidation of caffeine by CYP1A2: isotope effects and metabolic switching.
47. 2026-09-07srcFluvoxamine impairs single-dose caffeine clearance without altering caffeine pharmacodynamics.
48. 2026-09-07srcCaffeine — PubChem CID 2519
49. 2026-09-07srcCaffeine and sports activity: a review.
50. 2026-09-07srcBiotransformation of caffeine in human liver microsomes from foetuses, neonates, infants and adults.
51. 2026-09-07srcCaffeine dependence syndrome. Evidence from case histories and experimental evaluations.
52. 2026-09-07srcA fluvoxamine-caffeine interaction study.
53. 2026-09-07srcCaffeine history: isolation by Runge 1819, synthesis by Fischer 1895
54. 2026-09-07srcCaffeine physical properties: melting point, solubility, CAS
55. 2026-09-04issueIssued emergency
56. 2026-09-04issueIssued info_card
57. 2026-09-04issueIssued notice
58. 2026-06-04proposal29 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
59. 2026-06-04publicationPublication — backfill
60. 2026-04-25revisionRevision 1
61. 2026-04-25absenceSearched cross-reference for "Primary ROA discrepancy: seed data says insufflated, evidence review" — no results
62. 2026-04-25absenceSearched PubMed for "caffeine sleep quality adenosine polysomnography" — no results
63. 2026-04-25genGeneration — pipeline-v5 · with 1 morepipeline-v5
64. 2026-04-25rungeneration run
65. 2026-04-25rungeneration run

The same entries, as forms: six forms.